Fucose Binding Cancels out Mechanical Differences between Distinct Human Noroviruses

Viruses. 2023 Jun 30;15(7):1482. doi: 10.3390/v15071482.

Abstract

The majority of nonbacterial gastroenteritis in humans and livestock is caused by noroviruses. Like most RNA viruses, frequent mutations result in various norovirus variants. The strain-dependent binding profiles of noroviruses to fucose are supposed to facilitate norovirus infection. It remains unclear, however, what the molecular mechanism behind strain-dependent functioning is. In this study, by applying atomic force microscopy (AFM) nanoindentation technology, we studied norovirus-like particles (noroVLPs) of three distinct human norovirus variants. We found differences in viral mechanical properties even between the norovirus variants from the same genogroup. The noroVLPs were then subjected to fucose treatment. Surprisingly, after fucose treatment, the previously found considerable differences in viral mechanical properties among these variants were diminished. We attribute a dynamic switch of the norovirus P domain upon fucose binding to the reduced differences in viral mechanical properties across the tested norovirus variants. These findings shed light on the mechanisms used by norovirus capsids to adapt to environmental changes and, possibly, increase cell infection. Hereby, a new step towards connecting viral mechanical properties to viral prevalence is taken.

Keywords: AFM; mechanical properties; nanoindentation; norovirus-like particles (noroVLPs); virus-ligand interaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caliciviridae Infections*
  • Capsid / metabolism
  • Capsid Proteins / genetics
  • Fucose / chemistry
  • Fucose / metabolism
  • Humans
  • Mutation
  • Norovirus* / metabolism

Substances

  • Fucose
  • Capsid Proteins

Grants and funding

The Leibniz Institute of Virology is supported by the Free and Hanseatic City Hamburg and the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). C.U. acknowledges funding from the Leibniz Association through SAW-2014-HPI-4 grant. R.P., J.M.-G., C.U., Y.F., W.H.R., and L.T. acknowledge funding from EU Horizon 2020 project VIRUSCAN 731868. C.U., R.P., and L.T. acknowledge further funding from EU Horizon 2020 project ARIADNE VIBE 954553.